HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity.

AbstractBACKGROUND:
Atopic dermatitis (AD) is an inflammatory skin condition that can occur in early life, predisposing to asthma development in a phenomenon known as the atopic march. Although genetic and environmental factors are known to contribute to AD and asthma, the mechanisms underlying the atopic march remain poorly understood. Filaggrin loss-of-function mutations are a major genetic predisposer for the development of AD and progression to AD-associated asthma.
OBJECTIVE:
We sought to experimentally address whether filaggrin mutations in mice lead to the development of spontaneous eczematous inflammation and address the aberrant immunologic milieu arising in a mouse model of filaggrin deficiency.
METHODS:
Filaggrin mutant mice were generated on the proallergic BALB/c background, creating a novel model for the assessment of spontaneous AD-like inflammation. Independently recruited AD case collections were analyzed to define associations between filaggrin mutations and immunologic phenotypes.
RESULTS:
Filaggrin-deficient mice on a BALB/c background had profound spontaneous AD-like inflammation with progression to compromised pulmonary function with age, reflecting the atopic march in patients with AD. Strikingly, skin inflammation occurs independently of adaptive immunity and is associated with cutaneous expansion of IL-5-producing type 2 innate lymphoid cells. Furthermore, subjects with filaggrin mutations have an increased frequency of type 2 innate lymphoid cells in the skin in comparison with control subjects.
CONCLUSION:
This study provides new insights into our understanding of the atopic march, with innate immunity initiating dermatitis and the adaptive immunity required for subsequent development of compromised lung function.
AuthorsSean P Saunders, Tara Moran, Achilleas Floudas, Felicity Wurlod, Agnieszka Kaszlikowska, Maryam Salimi, Emma M Quinn, Christopher J Oliphant, Gabriel Núñez, Ross McManus, Emily Hams, Alan D Irvine, Andrew N J McKenzie, Graham S Ogg, Padraic G Fallon
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 137 Issue 2 Pg. 482-91 (Feb 2016) ISSN: 1097-6825 [Electronic] United States
PMID26299987 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
Chemical References
  • FLG protein, human
  • Filaggrin Proteins
  • Intermediate Filament Proteins
Topics
  • Adaptive Immunity
  • Animals
  • Dermatitis, Atopic (complications, genetics, immunology, pathology)
  • Disease Models, Animal
  • Filaggrin Proteins
  • Immunity, Innate
  • Intermediate Filament Proteins (deficiency, genetics)
  • Lymphocytes (immunology, metabolism, pathology)
  • Mice
  • Mice, Transgenic
  • Mutation
  • Phenotype
  • Pneumonia (etiology, pathology)
  • Skin (immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: